Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| IDO-IN-11 | C19H23BrFN7O4S | 1888378-32-2 | Details |
| IDH1 Inhibitor 1 | C20H18F4N6O2 | 2234285-81-3 | Details |
| IDO-IN-12 | C13H11BrFN5O3S | 1888341-29-4 | Details |
| IDO-IN-3 | C11H12BrFN6O2 | 2070018-30-1 | Details |
| IDO-IN-13 | C26H17F3N4O | 2291164-02-6 | Details |
| IDO-IN-5；NLG-1489 | C18H21FN2O2 | 1402837-79-9 | Details |
| IDO-IN-6；NLG-1486 | C18H21FN2O2 | 1402837-76-6 | Details |
| IDO-IN-4 | C26H35N3O3 | 1629125-65-0 | Details |
| Acipimox | C6H6N2O3 | 51037-30-0 | Details |
| IDO-IN-8；NLG-1487 | C18H21FN2O2 | 1402837-77-7 | Details |
| IDO1 and HDAC1 Inhibitor | C25H22BrFN8O4 | 2227044-16-6 | Details |
| IDO1-IN-2 | C15H17FN6O4 | 2346614-58-0 | Details |
| Betamethasone valerate | C27H37FO6 | 2152-44-5 | Details |
| iFSP1 | C20H13N5 | 150651-39-1 | Details |
| IFN alpha-IFNAR-IN-1 | C18H17NS | 844882-93-5 | Details |
| Ifenprodil glucuronide | C27H35NO8 | 66516-92-5 | Details |
| IACS-8968 S-enantiomer；IDO/TDO Inhibitor (S-enantiomer) | C17H18F3N5O2 | 2239305-70-3 | Details |
| IDO-IN-9 | C13H13BrFN7O3S | 1888378-12-8 | Details |
| IDO/TDO-IN-1 | C25H24FN5 | 2033173-01-0 | Details |
| IACS-8968 R-enantiomer；IDO/TDO Inhibitor (R-enantiomer) | C17H18F3N5O2 | 2239305-67-8 | Details |
| IACS-8968；IDO/TDO Inhibitor | C17H18F3N5O2 | 2144425-14-7 | Details |
| IFN alpha-IFNAR-IN-1 hydrochloride | C18H18ClNS | 2070014-98-9 | Details |
| N-Desmethyl imatinib | C28H29N7O | 404844-02-6 | Details |
| Irbesartan-d4；BMS-186295 D4;SR-47436 D4;Irbesartan D4 | C25H28N6O | 1216883-23-6 | Details |
| Insulin levels modulator | C21H23N7OS | 1019254-94-4 | Details |
| Imidaprilate；6366A;Imidaprilat | C18H23N3O6 | 89371-44-8 | Details |
| Impurity C of Calcitriol | C35H49N3O5 | 86307-44-0 | Details |
| Impurity B of Calcitriol；1β,25-Dihydroxyvitamin-D3;1-Epicalcitriol | C27H44O3 | 66791-71-7 | Details |
| Ivabradine-d6 hydrochloride；Ivabradine D6 hydrochloride | C??H??D?ClN?O? | 2070009-63-9 | Details |
| Londamocitinib | C28H31F2N7O4S | 2241039-81-4 | Details |
| JAK2/FLT3-IN-1 | C25H34FN7O | 2387765-27-5 | Details |
| IT1t dihydrochloride | C21H35ClN4S2 | 1092776-63-0 | Details |
| J-113863 | C30H37Cl2IN2O2 | 353791-85-2 | Details |
| INO5042 | C15H7NO3S | 14782-19-5 | Details |
| Indoramin D5；Wy-21901 D5;Indoramine D5 | C8H3D5N2 | 57165-41-0 | Details |
| IPR-803 | C27H23N3O4 | 892243-35-5 | Details |
| IQB-782 | C4H9N3O2S | 40454-21-5 | Details |
| Impurity F of Calcipotriol | C39H68O3Si2 | 112875-61-3 | Details |
| INCB 3284 | C26H31F3N4O4 | 887401-92-5 | Details |
| IRAK inhibitor 3 | C21H21N5O4S | 1012343-93-9 | Details |
| Ionomycin calcium；SQ23377 calcium | C41H70CaO9 | 56092-82-1 | Details |
| Ipragliflozin (L-Proline)；Ipragliflozin L-Proline | C21H21FO5S.C5H9NO2 | 951382-34-6 | Details |
| IRAK4-IN-4 | C22H16N2O2 | 1850276-58-2 | Details |
| INCB 3284 dimesylate | C26H31F3N4O4 | 887401-93-6 | Details |
| IR415 | C13H14F2N4S | 452967-14-5 | Details |
| Desonide | C24H32O6 | 638-94-8 | Details |
| Isoasatone A | C24H32O8 | 67451-73-4 | Details |
| INCB054329 Racemate | C19H16N4O3 | 1628607-62-4 | Details |
| Indanidine | C11H13N5 | 85392-79-6 | Details |
| Iriflophenone 3-C-glucoside | C19H20O10 | 104669-02-5 | Details |
| Indirubin Derivative E804 | C20H19N3O4 | 854171-35-0 | Details |
| Indirubin-5-sulfonate | C16H10N2O5S | 244021-67-8 | Details |
| Indirubin-3'-monoxime-5-sulphonic acid | C16H11N3O5S | 331467-05-1 | Details |
| Ethionamide | C8H10N2S | 536-33-4 | Details |
| Integrin-IN-2 | C27H30N4O3 | 2378617-67-3 | Details |
| INT-777 R-enantiomer；S-EMCA R enantiomer | C27H46O5 | 1198786-98-9 | Details |
| Irindalone；Lu 21-?098 | C24H29FN4O | 96478-43-2 | Details |
| INH154 | C22H24N4OS | 1587705-63-2 | Details |
| Isavuconazole-d4；BAL-4815 D4;RO-0094815 D4;Isavuconazole D4 | C22H17F2N5OS | 1346598-58-0 | Details |
| Iristectorin B | C23H24O12 | 94396-09-5 | Details |
| Inogatran；H-314-27 | C21H38N6O4 | 155415-08-0 | Details |
| Cyproterone acetate；Androcur;Cyproterone 17-O-acetate | C24H29ClO4 | 427-51-0 | Details |
| IRAK inhibitor 4 | C33H35F3N6O3 | 1012104-68-5 | Details |
| J22352 | C24H21N3O4 | 2252395-44-9 | Details |
| Ivachtin；Caspase-3 Inhibitor VII | C20H21N3O7S | 745046-84-8 | Details |
| N-Demethyl ivabradine hydrochloride；Ivabradine metabolite N-Demethyl Ivabradine hydrochloride | C26H35ClN2O5 | 1246638-08-3 | Details |
| IX 207-887 | C16H12O3S | 98320-39-9 | Details |
| Imatinib-d8；STI571 D8;CGP-57148B D8;Imatinib D8 | C29H23N7OD8 | 1092942-82-9 | Details |
| IKK-IN-1 | C22H26ClN3O4 | 406211-06-1 | Details |
| IL-15-IN-1 | C30H36N6O4S | 1831830-20-6 | Details |
| IL-17A antagonist 1 | C33H41FN6O4 | 2205034-18-8 | Details |
| Imatinib D4；STI571 D4;CGP-57148B D4 | C29H31N7O | 1134803-16-9 | Details |
| Iloperidone metabolite Hydroxy Iloperidone；P88;Hydroxy Iloperidone | C24H29FN2O4 | 133454-55-4 | Details |
| IIIM-290 | C23H21Cl2NO5 | 2213468-64-3 | Details |
| IL-17A antagonist 3 | C33H33ClN6O4 | 2230780-65-9 | Details |
| Ilorasertib hydrochloride；ABT-348 hydrochloride | C25H22ClFN6O2S | 1847485-91-9 | Details |
| INT-767 | C25H45NaO6S | 1000403-03-1 | Details |
| INT-777 | C27H46O5 | 1199796-29-6 | Details |
| Indomethacin-D4；Indometacin-D4 | C19H16ClNO4 | 87377-08-0 | Details |
| Impurity C of Alfacalcidol | C35H49N3O4 | 82266-85-1 | Details |
| JAK-IN-1 | C20H24N6O2 | 1334673-53-8 | Details |
| JAK-IN-3 | C18H20N4O3 | 1400876-94-9 | Details |
| JAK-IN-4 | C18H22N4NaO6P | 1400877-37-3 | Details |
| Ivabradine-d3 hydrochloride；Ivabradine D3 Hydrochloride | C27H37ClN2O5 | 1217809-61-4 | Details |
| IT1t | C21H34N4S2 | 864677-55-4 | Details |
| Isotanshinone I | C18H12O3 | 20958-17-2 | Details |
| IV-23 | C18H18BrNO4 | 2326007-49-0 | Details |
| Moguisteine | C16H21NO5S | 119637-67-1 | Details |
| Itacitinib adipate | C32H33F4N9O5 | 1334302-63-4 | Details |
| ITI-214 free base；ITI214 free base | C29H26FN7O | 1160521-50-5 | Details |
| Isochondrodendrine；Isochondrodendrin | C36H38N2O6 | 477-62-3 | Details |
| Isoglycycoumarin | C21H20O6 | 117038-82-1 | Details |
| Olopatadine hydrochloride | C21H24ClNO3 | 140462-76-6 | Details |
| J30-8 | C17H9ClFN3O2S | 2366255-71-0 | Details |
| IZCZ-3 | C46H49N7O | 2223019-53-0 | Details |
| J-2156 | C24H28N4O4S | 848647-56-3 | Details |
| ITK inhibitor 2 | C25H33N5O2 | 1309784-09-5 | Details |
| ITI-214 | C29H29FN7O5P | 1642303-38-5 | Details |
| Isolongifolene | C15H24 | 1135-66-6 | Details |
| Isoguvacine hydrochloride | C6H9NO2HCl | 68547-97-7 | Details |
| Product Total： Product Page： | ||||
| 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 | ||||